Literature DB >> 27278046

Left atrial appendage occlusion device-related thrombus: a case report and review of the literature.

Mohammed Andaleeb Chowdhury1, Wael Elabbassi2, Arif Al Nooryani1.   

Abstract

A 75-year-old male with persistent atrial fibrillation underwent implantation of a left atrial occlusion device. After 6 weeks, a scheduled trans-esophageal echocardiogram showed a 1.1-cm × 1.1-cm mass within the occluded left atrial appendage, suspected to be thrombus. He was continued on warfarin for an additional 6 weeks and a repeat trans-esophageal echocardiogram showed obliteration of the left atrial appendage. This report describes an uncommon observation detected at scheduled follow up by trans-esophageal echocardiogram, which sheds some light on the mechanism by which this device "matures" after it is implanted inside the left atrial appendage.

Entities:  

Keywords:  Atrial fibrillation; Device-related thrombus; Left atrial appendage occlusion; Watchman

Year:  2012        PMID： 27278046     DOI： 10.1007/s12574-012-0115-3

Source DB:  PubMed          Journal:  J Echocardiogr        ISSN： 1349-0222


  6 in total

1.  ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology.

Authors:  V Fuster; L E Rydén; R W Asinger; D S Cannom; H J Crijns; R L Frye; J L Halperin; G N Kay; W W Klein; S Lévy; R L McNamara; E N Prystowsky; L S Wann; D G Wyse; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; G Gregoratos; L F Hiratzka; A K Jacobs; R O Russell; S C Smith; W W Klein; A Alonso-Garcia; C Blomström-Lundqvist; G de Backer; M Flather; J Hradec; A Oto; A Parkhomenko; S Silber; A Torbicki
Journal:  Circulation       Date:  2001-10-23       Impact factor: 29.690

2.  The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial.

Authors:  Rebecca Brown Fountain; David R Holmes; Krishnaswamy Chandrasekaran; Douglas Packer; Samuel Asirvatham; Robert Van Tassel; Zoltan Turi
Journal:  Am Heart J       Date:  2006-05       Impact factor: 4.749

3.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

4.  Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.

Authors:  Vivek Y Reddy; David Holmes; Shephal K Doshi; Petr Neuzil; Saibal Kar
Journal:  Circulation       Date:  2011-01-17       Impact factor: 29.690

5.  Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation.

Authors:  Peter B Sick; Gerhard Schuler; Karl Eugen Hauptmann; Eberhard Grube; Steve Yakubov; Zoltan G Turi; Gregory Mishkel; Steve Almany; David R Holmes
Journal:  J Am Coll Cardiol       Date:  2007-03-21       Impact factor: 24.094

6.  Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study.

Authors:  M F Stoddard; P R Dawkins; C R Prince; N M Ammash
Journal:  J Am Coll Cardiol       Date:  1995-02       Impact factor: 24.094
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.